UNSPSC 51283108: Colistimethate sodium

This classification denotes an antimicrobial solution, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier XW0E5YS77G. European Medicines Agency schedules Colistimethate sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06801MIG. Colistimethate sodium generally arises in the molecular formula C57H103N16NA5O28S5.

The term COLISTIMETHATE SODIUM is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 38, no. 6, 1984, list 24.) Most nations, for tariff and trade purposes, schedule colistimethate sodium under HS 29419000 and SITC 54139. Colistimethate sodium bears US NLM identifiers UMLS ID C0110462 and NCI Concept Code C65349. SMILES: As of Q4 2014, COLISTIMETHATE SODIUM remains US FDA's Preferred Term for this commodity.

UNSPSC 51283108 Colistimethate sodium is a Commodity code that in practice captures pharmaceutical procurement by state and local health agencies, though recent opportunities tagged under this code show limited alignment with the nominal product name. The work being solicited includes pharmaceutical warehouse supply contracts and public health pharmaceutical acquisitions. Issuing bodies are primarily state health departments and county public health authorities pursuing competitive procurement of medications and related health-support systems to support emergency preparedness, community health initiatives, and disease prevention programs.

Activity under the code is geographically dispersed across Florida and Illinois based on recent opportunities. The Illinois Department of Public Health awarded a piggyback pharmaceutical contract through the MMCAP Infuse consortium to Chartwell Rx LLC on August 28, 2026 (Solicitation 26482DPHPREPDB53392) for Doxycycline Hyclate 100mg and Ciprofloxacin Hydrochloride 500mg tablets over a 36-month period with a total award of $2,999,999.11; Seminole County, Florida released an IFB (IFB60459723LAS) on June 30, 2026 with a July 26, 2023 response deadline seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries to the Seminole County Community Health Building. Both procurements require electronic bid submission and specify inclusive delivery and shipping costs; the Illinois award proceeded as an Invitation for Bid under a cooperative purchasing vehicle, while the Seminole County opportunity included FEMA-potential funding with associated federal compliance requirements.